Unknown

Dataset Information

Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study.


ABSTRACT:

Background

A competitive market for off-patent biologicals leads to more affordable and high-quality healthcare. In recent years, Belgium has been characterized by its low use of biosimilars and by its shifts from off-patent biologicals toward new alternative therapies. Yet, the prescribing decisions involved in these observations are poorly understood. This study aims to better understand prescribing choices among Belgian physicians in the ambulatory care setting.

Methods

This study consisted of two phases. First, a scoping literature review to identify determinants of prescribing choices was conducted. Scientific databases (Embase and PubMed) were searched until 4 November 2021. Second, the nominal group technique (NGT) was employed during focus group discussions with Belg

SUBMITTER: Vandenplas Y 

PROVIDER: S-EPMC9520107 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature